NEW YORK (GenomeWeb News) - Gene synthesis firm GeneArt will generate 2,000 to 3,000 genes and gene variants for the National Cancer Institute, under a contract worth as much as $6.5 million, the company said today.
The contract was assigned by SAIC-Frederick through the National Institutes of Health's Mammalian Gene Collection Program, which aims to create a cDNA library that includes a full-length clone of each known human and mouse gene.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.